[Webinar Recap] What You Need to Know About Preventing Fraud, Waste & Abuse
Know everything you need to know about protecting your organization from pharmacy benefit fraud, waste and abuse? Chances are you don't - that's why...
Using PMPM to Measure True Bottom Line Costs
Comparing one PBM to another is very complex. To add to it, many metrics are available to help you understand if you’re getting a good deal or not....
2022 Pharmacy Benefit Predictions: What Plan Sponsors Should Watch
Navitus’ CEO, David Fields, shares his insights into the pharmacy benefits industry that will help plan sponsors achieve greater cost savings,...
[Webinar Recap] An Evidence-Based Approach to Population Health
Plans can leverage population health management programs to achieve better health outcomes. Learn a few best practices in today’s blog.
In the Pipeline: Specialty Drugs to Watch in 2022
Specialty medication development has grown rapidly, encompassing up to 80% of new FDA drug approvals in recent years. Read on to learn about the most...
In the Pipeline: Non-Specialty Drugs to Watch in 2022
Our pharmacists are always monitoring the drug development pipeline to help plan sponsors stay ahead of the curve on new and upcoming medications....
Using UM Strategies to Better Manage Rx Costs and Improve Health (rerun)
Utilization management (UM) programs serve as a gatekeeper to the formulary, working to ensure appropriate, cost-effective medication use. They can...
3 Key PBM Revenue Streams You Need to Know
Understanding how pharmacy benefit managers (PBMs) make money can help plan sponsors determine which PBM business model is best for their Rx plan –...
[Webinar] How to Better Manage Specialty Drug Spend for Chronic Conditions
Didn’t have time to attend our recent webinar on managing chronic conditions? Don’t worry – we’ve got you covered with a recap!
Is Your PBM More Like Cable or Streaming?
Deciding to switch service providers can be difficult, whether it's your cable or your pharmacy benefit manager. But sometimes it's necessary.
